A team of paleogeneticists is a winner of the 2024 Gizmodo Science Fair for recovering RNA from a museum specimen of a ...
Goldman Sachs has initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) based on multi-blockbuster, first-to-market ...
Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...
"This could be a game-changer for treating complex conditions where targeting multiple pathways is beneficial, such as cancer ...
A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...
Aptadir Therapeutics (Aptadir), a biotech company developing RNA inhibitor-based therapeutics for treating intractable ...
Aptadir Therapeutics, a biotech focused on RNA inhibitor therapies for cancer and genetic conditions, has launched with $1.6 ...
Long known as a messenger within cells, RNA is increasingly seen as life’s molecular communication system — even between ...
The life-saving use of messenger RNA (mRNA) in COVID-19 vaccines was a public example of the potential of mRNA-based ...
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...
RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...
TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribe™ RNA Polymerase, a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback